Why is Shree Ganesh Bio falling/rising?

As of 10-Sep, Shree Ganesh Biotech India Ltd is currently priced at 0.79, showing no change (0.00%). The stock has outperformed its sector by 1.2% today, but it is important to note that the delivery volume has decreased by 19.97% compared to the 5-day average, indicating falling investor participation. In terms of returns, the stock has seen a 5.33% increase over the past week, but it has significantly underperformed over longer periods, with a year-to-date decline of 24.04% and a staggering 85.64% drop over the past five years. The company is facing challenges, including operating losses and a weak ability to service its debt, which is reflected in its poor EBIT to Interest ratio of 0.97 and a low return on equity of 2.52%. These factors contribute to a perception of the stock as a strong sell.
In the broader market context, the Sensex has increased by 1.06% over the past week, while Shree Ganesh Biotech's short-term performance has been more favorable in comparison. However, the stock's long-term performance is concerning, as it has generated a return of -30.09% over the past year, while the Sensex has remained relatively flat with a decline of only 0.61%. This stark contrast highlights the company's struggles against a backdrop of a generally stable market, reinforcing the notion that despite some short-term gains, the overall outlook for Shree Ganesh Biotech remains negative due to its fundamental weaknesses.